SCHEMBL19081429

SCHEMBL19081429

c1ccc(-c2c3ccccc3c(-c3ccc4c(c3)oc3cc5c(cc34)oc3ccc4ccccc4c35)c3ccccc23)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 7/20 0.46
CYP1A1 P04798 3/20 0.46
CYP1A2 P05177 3/20 0.46
PAX8 Q06710 2/20 0.46
AHR P35869 2/20 0.46
FYN P06241 1/20 0.46
MAPK3 P27361 1/20 0.46
TDP1 Q9NUW8 4/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 1/20 0.39
KDM4E B2RXH2 3/20 0.38
MAPT P10636 3/20 0.38
HPGD P15428 3/20 0.38
TSHR P16473 3/20 0.38
HSD17B10 Q99714 3/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
GLA P06280 1/20 0.38
HTT P42858 1/20 0.38
ALDH1A1 P00352 2/20 0.37
ALOX15 P16050 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081515 0.96 ABCG2 (0.43) ABCG2CYP1A1CYP1A2PAX8AHR
SCHEMBL19081625 0.96 ABCG2 (0.43) ABCG2CYP1A1CYP1A2PAX8AHR
SCHEMBL22680709 0.96 ABCG2 (0.45) ABCG2CYP1A1CYP1A2PAX8AHR
SCHEMBL23426912 0.96 ABCG2 (0.45) ABCG2CYP1A1CYP1A2PAX8AHR
SCHEMBL23427715 0.96 ABCG2 (0.45) ABCG2CYP1A1CYP1A2PAX8AHR
SCHEMBL19081478 0.93 ABCG2 (0.43) ABCG2CYP1A1CYP1A2PAX8AHR
SCHEMBL17943926 0.93 ABCG2 (0.45) ABCG2CYP1A1CYP1A2PAX8AHR
SCHEMBL18268607 0.93 ABCG2 (0.47) ABCG2CYP1A1CYP1A2PAX8AHR
SCHEMBL17945198 0.93 ABCG2 (0.47) ABCG2CYP1A1CYP1A2PAX8AHR
SCHEMBL15461366 0.93 ABCG2 (0.49) ABCG2CYP1A1CYP1A2PAX8AHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 ABCG2 4823/4885CYP1A1 184/4885CYP1A2 659/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 ABCG2 4823/4885CYP1A1 184/4885CYP1A2 659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.